+ All Categories
Home > Documents > 2 and 3 Chem Amino Acids Protein Struc Faust CS02 03

2 and 3 Chem Amino Acids Protein Struc Faust CS02 03

Date post: 03-Mar-2016
Category:
Upload: niloy-ghosh
View: 225 times
Download: 0 times
Share this document with a friend
Description:
Amino Acids

of 15

Transcript
  • Contact Information Introduction to Polypeptides

    1. Central to All Aspects of Life

    2. Most Abundant Macromolecules

    3. Linear Polymers (20 Amino Acids)

    4. Peptide Bond - covalent amide linkage

    5. Polypeptide Lengths: 10,000 a.a.

    6. Average Length - about 500 amino acids

    7. Very High Sequence Diversity, X = 20n

    Astronomical Numbers of Proteins Are Possible!!!

    High sequence diversity means a high number of possibilities, X, since X = 20n,

    where n is the number of amino acids in the polypeptide length, and

    X is the total number of permutations available, i.e., the total amount of polypeptide sequence diversity, e.g.,

    (20)2 = 400 different dipeptides (dimer),

    (20)3 = 8,000 different tripeptides (trimer),

    (20)6 = 64 (10)6 different hexapeptides (hexamer), and

    (20)500 = 3.2 (10)600 different polypeptides (500-mers) .

    Life Requires Only a Very Small

    Subset of All These Possibilities

    3.2 (10)600 total possibilities for 500 a.a.

    Only about (10)7 are actually used in man.

    So, at least (10)593 of the (10)600 are never used for the 500-mer population.

  • 19 Amino Acids Have an

    Asymmetric* Central Carbon.

    ACC ()

    Tetrahedron

    (pyramid)

    *Glycine is NOT asymmetric.

    P

    D

    (chiral)

    P = Protonated D = Deprotonated

    (see page 16)

    5

    Protonation and Deprotonation

    -NH2

    -COOH zwitterion

    (Three Protonation States)

    (pI)

    (see page 17)

    Titration Curve of Alanine

    pI = 6.1 (net charge = 0)

    pK* (-carboxyl) = 2.3

    pK* (-amino) = 9.9

    *NOTE: Best Buffering Occurs in the Flat Parts

    (see page 17)

    Titration of Complex Amino Acids

    (Four Protonation States with an Ionizable Side Chain)

    Acidic

    (asp)

    Basic

    (lys)

    pI

    pI

    pI

    (see page 17)

  • pH = 7

    14

    1

    [H]+ = [OH]-, (H2O, pK* = 7)

    OH- ion excess

    H+ ion excess, [H3O]+

    Deprotonation, -H+

    Protonation, +H+

    *NOTE: when pH = pK, 50% P + 50% D [1:1]

    SIMPLE PRINCIPLES OF PROTONATION/DEPROTONATION

    more

    acidic

    more

    basic

    H2O

    more

    basic

    more

    acidic

    pH = 7

    14

    1

    [H]+ = [OH]-, (H2O, pK* = 7)

    OH- ion excess

    H+ ion excess

    pH = pKbasic*

    pH = pKacidic*

    Deprotonation, -H+

    Protonation , +H+

    *NOTE: when pH = pK, 50% P + 50% D [1:1]

    SIMPLE PRINCIPLES OF PROTONATION/DEPROTONATION

    more

    acidic

    more

    basic

    Net neg.

    charge

    charge

    loss Net pos.

    charge

    charge

    loss

    10

    Two Classes of Amino Acids *

    1. Hydrophilic (POLAR: loving water) - side chains (R) generally have O, N or S, viz., the 3 subgroups of basic, acidic and neutral

    2. Hydrophobic (NONPOLAR: fearing water) - side chains (R) have straight, branched or cyclic carbon structures, viz., aliphatic and aromatic

    *NOTE: know all 20 of the 3 letter abbreviations

    Hydrophilic Amino Acids

    (3 groups)

    BASIC ACIDIC NEUTRAL

    Arg Asp Ser Lys Glu Thr

    His Asn

    Gln

    Cys*

    Met*

    *These are very weakly hydrophilic as free amino

    acids, but in proteins they are usually hydrophobic.

  • Hydrophobic Amino Acids

    (2 groups)

    Gly Phe

    Ala Tyr

    Val Trp Leu

    Ile

    Pro (aliphatic ring)

    ALIPHATIC Chains AROMATIC Rings

    Free*

    *

    not ionized

    (physiological pH ~ 7.3)

    (see page 19)

    Protein Structure: Dictated by

    Strong & Weak Chemical Bonds

    15

    Protein Structure: Hierarchy

    of Four Basic Structural Levels

    1. Primary, 1o: linear a.a. sequence (covalent bond)

    2. Secondary, 2o: -helix, -sheet & -turn (H-bond)

    3. Tertiary, 3o: final native 3D shape (hydrophobic)

    4. Quaternary, 4o: association of multiple polypep-tides to make one protein (stabilized by all four weak, noncovalent bonds; maybe covalent ones)

  • Polypeptide Formation: 1o

    A. Peptide covalent bond formation

    B. Peptide chain polarity

    Free

    terminus

    Free

    terminus

    (N C)

    * * * * *

    Amide Bond

    *- C

    (see page 20)

    Polypeptide Modifications

    1. Blocking termini (covalent)

    2. Disulfide bond formation (covalent)

    Cystine (diamino acid)

    3. Cystine occurrence (follows food digestion)

    Helps to Stabilize:

    2o

    3o

    4o

    Peptide Bond is Rigid*

    -

    +

    *(All in same plane)

    H

    OH

    H O

    H O

    H

    H + + -

    Trans ( )

    (see page 20)

    Secondary Structure: 2o

    1. All 2o Forms Are Stabilized by H-bonds.

    2. Secondary Structure Forms Include: a. -helices (mostly right-handed) b. -pleated sheets - 2 basic types 1) Parallel

    2) Antiparallel

    c. -turns (hairpin turns)

    20

  • Right-handed -Helix (2o)

    All R groups

    point away

    from -helix

    N

    C

    Polarity

    Minimizes

    Steric clash

    R2 R1

    R3

    R4 R5

    R6

    R7

    R8

    Hydrogen bond

    Side groups

    H2N-

    HOOC

    Parallel -Sheet (2o)

    Parallel

    strands

    1 2 3

    N

    C

    Polarity

    All R groups

    point away

    from -sheet

    Polarity (see page 21)

    3D Schematic of -pleated Sheet

    Parallel

    N

    N

    C

    C

    Parallel -Sheet (2o) (A Single Polypeptide)

    N

    C

  • Anti-Parallel -Sheet (2o)

    Anti-parallel

    strands

    1 2

    3 Polarity

    N

    C

    Polarity

    All R groups

    point away

    from -sheet

    (see page 21)

    25

    3D Schematic of -pleated Sheet

    Anti-parallel

    N

    N

    C

    C

    Anti-Parallel -Sheet (2o) (A Single Polypeptide)

    C

    N

    -Turn (2o)

    .

    .

    .

    . . .

    .

    .

    . .

    .

    . .

    .

    .

    H-bond

    (R)

  • Tertiary Structure (3o):

    the Native 3D shape

    1. Hydrophobic interactions are the principal stabilizing force of tertiary structure.

    2. Core is mainly hydrophobic side chains.

    3. Domains are discreetly packed elements that result from hydrophobic side chain packing

    and assembling of all secondary structures.

    4. Tertiary structures may have 1 domain or more.

    Tertiary Structure: One Domain

    (basic immunoglobulin domain)

    -S-S-

    30

    Two Domains (or more, 3o) Bence Jones proteins: Multiple myeloma

    -S-S-

    NH2

    HOOC

    Quaternary Structure (4o):

    Multimeric Proteins (Hb)

  • Polypeptide Folding Events

    1. Peptide bond formation occurs first (1o). 2. Primary structure contains folding instructions. 3. Chaperones can provide folding assistance. 4. Chaperones can also correct some misfolding. 5. But polypeptides are

    degraded back to simple amino acids in

    organelle structures called proteosomes.

    Protein Denaturation

    1. Loss of ALL higher ordered structures,

    i.e., complete unfolding of 2o, 3o & 4o,

    producing a polypeptide random coil.

    2. Various types of denaturants available:

    a. Heat () b. Detergents & organic solvents c. Strong acids and bases d. 8M urea and 6M guanidine HCl e. Heavy metals, e.g., Pd, Cd, Hg, etc.

    Protein Modifications

    1. Generally occur posttranslationally. 2. Over 500 different kinds are known. 3. Some more common ones include:

    a. Disulfide/sulfhydryl formation

    b. Phosphorylation (some regulatory)

    c. Glycosylation (O-linked & N-linked)

    d. Vitamin additions (co-factors).

    35

    Phosphorylation

    Phosphates joined

    to hydroxyl side

    chains (-OH), i.e.,

    1. Ser

    2. Thr

    3. Tyr

  • Glycosylation ( )

    Sugars joined

    to (-OH) side

    chains, i.e.,

    1. Ser

    2. Thr

    Sugar

    Glycosylation (N-linked)

    Sugar joined to

    Asn side chain

    (-NH2) only.

    Sugar

    Context:

    1. Asn-X-Ser 2. Asn-X-Thr

    X = Pro

    Biotin (Vitamin H) Addition

    Side Chain (-NH2)

    Lys only

    Biotin: a

    prosthetic

    group (1)

    Apoprotein (2)

    Holoprotein = (1 + 2)

    Disulfide Bond Reactivity

    irreversible

    reversible

    (see page 23)

    40

  • Protein Purification and

    Characterization Methods

    1. Proteins Absorb in the UV (@210 or 280 nm)

    2. Protein Solubility: surface side chains

    3. Dialysis: small contaminant removal

    4. Electrophoresis of Proteins

    a. Separation by charge

    b. Separation by size

    5. Structural characterizations: 1o, 2o, 3o, 4o

    UV Absorption Spectra

    peptide bond (210 nm)

    trp

    tyr

    phe

    (see page 24)

    (bases)

    Protein Solubility

    Distilled water: leads to mild attraction for some proteins

    +

    (see page 24)

    Protein Solubility

    Physiological or moderate salt (salting in):

    leads to weak repulsion of proteins

    Salting out: protein precipitation at high salt concentrations

    (salt ties up water, limiting protein solubility)

    (see page 24)

  • Protein Solubility

    Varies with different pHs

    (Excess H+) (Excess OH-)

    (Net charge = 0)

    < pI > pI

    pI

    OH -

    H +

    Net = 0

    -

    + (see page 24)

    45

    Dialysis: Small molecule removal

    time

    Cutoff:

    10 kDa

    (see page 25)

    Electrophoresis: Separation by Charge

    time

    (1-)

    (3-)

    (4-)

    (2-)

    Protein

    migration

    Protein

    Net Charge

    (see page 25)

    Electrophoresis: Separation by Size (Denaturing SDS PAGE)

    time

    25 kDa

    50 kDa

    100 kDa

    Largest

    Smallest

    Start Finish

    Sample: + SDS

    (see page 25)

  • Protein Structure Determination

    Primary: amino acid composition, peptide

    fragmentation, Edman degradation (for the

    sequence), and mass spectrometry (seq.)

    Secondary: CD and ORD (spectroscopies)

    Tertiary: X-ray diffraction and NMR

    Quaternary: X-ray diffraction, NMR & others

    1o Structure Characterization:

    Overlapping Peptide Mapping*

    *Edman degradation: yields pepide sequence (~50 aa, NC)

    *

    *

    *

    N C

    50

    Neurodegenerative Disorders (Diseases of malfolded proteins)

    1. Human Prion Diseases (amyloids: fibrous tangles)

    a. Bovine spongiform encephalopathy (BSE)

    b. Sporadic Creutzfeld-Jakob disease (1/106)

    c. Gerstmann-Straussler-Scheinker dis. (1/107)

    d. Fatal familial insomnia (1/107)

    e. Alpers syndrome: progressive infantile poliodystrophy

    f. Kuru (New Guinea tribe ancestor ritual, C. Gadjusek, 76)

    2. Alzheimers: aggregated protein (unprocessed?)

    3. Parkinsons: aggregated protein (unprocessed?)

    Human Prions

    1. Infectious protein: agent of all prion diseases

    2. Polypeptide: ~250 amino acids (S. Prusiner, 97)

    3. Only protein is infectious, i.e., no nucleic acid.

    4. Native form exists on nerve cell surfaces.

    5. Normal function remains unknown.

    6. Conformational change believed responsible for etiology of the disease condition.

  • Prion Structure & Properties

    1. Normal prion protein: 3 -helices 2. Abnormal protein: -sheet increases > 40% 3. Abnormal: resistant to proteolytic digestion

    4. Abnormal: induces conversion of metastable

    normal prions to stable abnormal prions

    5. Amyloid: neurotoxic fibrillar deposits

    6. Brain cell death ensues (apoptosis?)

    7. Prognosis: eventually the patient dies.

    Prion Conversion Mechanism: PrPC PrPSc

    Normal Prion

    Abnormal Prion (Long term process)

    Normal Type Disease Type

    PrPC PrPSc

    -Helix to -Sheet Conversion

    55

    Proposed Model of Prion

    Amyloid Fibril Formation

  • Prions: molecular genetics

    met/val asp (GAC/T)

    129* 178

    asn (AAC/T)

    CJD FFI

    wt-1o

    human

    ~250 a.a.

    mutation

    *met and val variants exist in general population

    Normal Human vs. vCJD Brain

    N vCJD (H&E) (H&E)

    Mouse Knock In Model: CJD

    (Human Diseased Prion Gene)

    H & E mAb HuP Mouse Brain Sections

    Alzheimers Disease

    60


Recommended